American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.
about
Bending the Cost Curve in Cancer CareImaging bone metastases in breast cancer: evidence on comparative test accuracyCancer biomarkersFuture directions for the early detection of recurrent breast cancerImpact of survivorship-based research on defining clinical care guidelines'Omic approaches to preventing or managing metastatic breast cancerAdjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerAssociations between cancer-related information seeking and receiving PET imaging for routine cancer surveillance--an analysis of longitudinal survey data.Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling.Use of physician services during the survivorship phase: a multi-province study of women diagnosed with breast cancer.A randomized controlled trial of physical activity, dietary habit, and distress management with the Leadership and Coaching for Health (LEACH) program for disease-free cancer survivors.Post-operative breast cancer patients diagnosed with skeletal metastasis without bone pain had fewer skeletal-related events and deaths than those with bone pain.Usefulness of (18)F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases.Surveillance mammography for Medicaid/Medicare breast cancer patientsOptimal approach in early breast cancer: Radiation therapyFDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysisUnderuse of long-term routine hospital follow-up care in patients with a history of breast cancer?Population-based longitudinal study of follow-up care for breast cancer survivorsQuality of cancer follow-up care: a focus on Latina breast cancer survivorsShould breast cancer survivors be excluded from, or invited to, organised mammography screening programmes?Primary care for young adult cancer survivors: an international perspective.The effect of surveillance on the outcome of breast cancer patientsRapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.Mandibular Metastasis of a Signet Ring Cell Carcinoma of the Breast in a Patient who Underwent Bilateral Mastectomy more than 25 Years Earlier.NHERF1/EBP50 in Breast Cancer: Clinical PerspectivesProposed follow up programme after curative resection for lower third oesophageal cancer.Follow-up care for breast cancer survivors: improving patient outcomes.Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancerOptions for early breast cancer follow-up in primary and secondary care - a systematic review.Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova ScotiaSurvivorship care plans in cancer: a systematic review of care plan outcomes.Health services utilisation in breast cancer survivors in Taiwan.Breast cancer survivorship issues.The reality in the surveillance of breast cancer survivors-results of a patient survey.International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatmentModels of care for early-stage breast cancer in CanadaBreast cancer "tailored follow-up" in Italian oncology units: a web-based survey.Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancerCaring for survivors of breast cancer: perspective of the primary care physicianA randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors.
P2860
Q22248106-70BF49D1-118E-4F60-9060-9F09CA828842Q26862731-E516CD5E-007E-412F-9BAB-18FA33A581EEQ26864429-15064B01-7C1B-4633-8AFF-407F2837DEC6Q27022040-99DA7366-80B8-4589-B44A-5AF61CB6032FQ27023522-C52C3A96-0642-41C8-A173-C359E84C9E08Q28730572-15831D78-7F98-46E8-B326-539836090148Q30430808-71199A08-5A8E-4D04-B0C5-64CF31CEDDB0Q30759702-26B9AB03-F461-463D-9BD2-7A15FFCB53D0Q33307797-DD6BB537-D340-4A90-BD72-918877A9B61DQ33611113-2E0978DF-52A9-4156-A5AE-7932E3E2D033Q33623513-F6D5D6CD-BBAA-434A-A8B2-CF381747BC3DQ33655631-FF87C61F-06B1-43F1-B4F4-14D6AD03AFE5Q33670025-452DC2C8-A939-4A47-B26C-C0A3E1376B2BQ33674887-FFEC078F-6633-4EDA-A526-47DA831B0F14Q33699050-285DD546-2ED6-45FD-8EAD-3F34034D06E3Q33868784-A33758D8-471A-4604-B86E-49DADF4851A7Q33943913-7335DC19-EDCB-497E-9122-C131443E3E29Q33978894-6FB80C1F-52D3-41A3-9DF0-EDC737EBB882Q34022706-1F029303-E1D0-4793-93DC-059C5943E2E5Q34039562-7C17D086-7EF0-4DFA-B817-BD2B9BD08FC8Q34072147-B925BB43-FBE0-4F54-9BA6-2100D8906547Q34082340-3E120269-DA51-457C-BEBA-31C3CF65617FQ34094242-F4D8C132-D087-4900-9222-9F44C8384A8BQ34095844-CC6B0FD4-1737-45BC-9E0A-08549978FBF3Q34096013-696940A9-B82F-4430-AC1E-225A6C33F234Q34133427-E940668C-48BB-4F67-937A-7FBC51516D67Q34140732-F540D05B-5B75-4EF7-9158-D1B69B521DFCQ34292779-EA35EB7E-4157-4E33-A7FB-A602EDACC369Q34303226-8B92AE6A-AD1E-4BF6-8D3E-8FDF94AC1F97Q34305926-73432018-3952-4F79-9399-D6E1FDF3E340Q34499673-C3EA4F48-79D0-4CCD-A381-935F204AA851Q34684144-4F7DD364-D1C1-47B2-9302-70CDDFB1154EQ34895561-930D2775-C17C-4A0F-B07D-0E5E6BFD6F61Q35015577-5A5B11D9-8AE4-43D3-9611-BB46C5D2A3A8Q35017523-75575534-B6DD-4435-8EAA-6A599A6F8C2FQ35059408-C2F28546-2827-4C3A-B6D3-1C71C589A5D8Q35143022-F3FAEC32-61C0-4931-82CB-89E3195EB39AQ35170200-02FF269A-C80F-4041-895A-6BA4679D416EQ35262382-3D924431-1770-4A9D-ABB4-67CC4619CD5CQ35545279-49C92446-6BB7-4AA7-BB62-BF2F3CFBF0E8
P2860
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
American Society of Clinical O ...... lines in the adjuvant setting.
@en
American Society of Clinical O ...... lines in the adjuvant setting.
@nl
type
label
American Society of Clinical O ...... lines in the adjuvant setting.
@en
American Society of Clinical O ...... lines in the adjuvant setting.
@nl
prefLabel
American Society of Clinical O ...... lines in the adjuvant setting.
@en
American Society of Clinical O ...... lines in the adjuvant setting.
@nl
P2093
P356
P1476
American Society of Clinical O ...... lines in the adjuvant setting.
@en
P2093
Eva Grunfeld
Francine Halberg
Hyman B Muss
James L Khatcheressian
Mark R Somerfield
Nancy E Davidson
Thomas J Smith
Victor G Vogel
P304
P356
10.1200/JCO.2006.08.8575
P407
P577
2006-10-10T00:00:00Z